EXOME

all the information, none of the junk | biotech • healthcare • life sciences

Following Merger, Salzman Steps in as Adverum Bio CEO

Xconomy San Francisco — 

Menlo Park, CA-based Adverum Biotechnologies (NASDAQ: ADVM) has named Amber Salzman, the company’s president and chief operating officer, its new CEO. Salzman takes over for Paul Cleveland, who will now serve as Adverum’s executive chairman. Adverum was formed out of the February merger between Avalanche Biotechnologies and Annapurna Therapeutics. Salzman co-founded Annapurna, once known as AAVLife, in 2014.